After mapping the first human genome back in 2000, Craig Venter has turned his attention to trying to decode death. He hopes to help people live to 100.
With the demand for direct-to-consumer genetic tests on the rise, a new analysis has questioned how reliable the results really are.
Color’s new DNA test identifies inherited heart conditions, where the idea is for customers to work with their doctor to come up with a plan to detect conditions early and prevent medical problems.
A new study suggests that how empathic we are is not just a result of our upbringing and experience but also partly a result of our genes.
Home genetic tests like AncestryDNA and 23andMe are more popular than ever. But having widespread access to personal genetic information—without the knowledge of how to interpret results—can lead to problems.
23andMe has received the first-ever FDA authorisation for a direct-to-consumer genetic test for cancer risk for its BRCA1 and BRCA2 report.
23andMe is updating its methods on its $99 genealogy test to trace ancestry back to 120 more populations, for a total of 151.
The number of people who have had their DNA analyzed with direct-to-consumer tests more than doubled during 2017, and now exceeds 12 million according to industry estimates.
A genomics startup co-founded by genetics pioneer George Church said yesterday that it seeks to lead the genomic data market by utilizing blockchain technology.
Reading the whole genetic blueprint of a fetus long before birth could become a routine procedure thanks to a new blood test.
A new consumer genomics test offers families immediately actionable information aimed at furthering the health of their youngest family members.